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It is well known that the genital skin may be affected by 
psoriasis. However, little is known about the prevalence 
and clinical appearance of genital psoriasis, and genital 
skin is often neglected in the treatment of psoriatic pa-
tients. We performed an extensive systematic literature 
search for evidence-based data on genital psoriasis with 
respect to epidemiology, aetiology, clinical and histopat-
hological presentation, diagnosis and treatment. Three 
bibliogra phical databases (PubMed, EMBASE and the 
Cochrane Library) were used as data sources. Fifty-nine 
articles on genital psoriasis were included. The results 
show that psoriasis frequently affects the genital skin, 
but that evidence-based data with respect to the efficacy 
and safety of treatments for genital psoriasis are extre-
mely limited. An advised treatment paradigm for genital 
psoriasis, based on the levels of evidence, is: first-line: 
(weak) topical corticosteroids; second-line: vitamin D 
preparations or tar-based treatments. Key words: psoria-
sis; inverse psoriasis; flexural psoriasis; male/female geni-
tal diseases; genital; treatment.
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A wide range of cutaneous diseases can affect the female 
and male genital skin. Some of these dermatoses are 
entirely or predominantly present in this region, while 
others, such as psoriasis, primarily involve non-genital 
skin.
Psoriasis is a chronic, inflammatory epidermal skin 
disease with a high prevalence in the general population 
of approximately 2% (1–3). It is one of the most com-
monly seen dermatoses of genital skin, although often 
limited attention is paid to the genital presentation of this 
skin disease. In many cases, genital psoriasis is part of a 
more generalised plaque psoriasis, although the external 
genitalia may be the only area affected. However, the 
isolated presentation of psoriasis solely on genital skin 
seems to be rare and occurs in only 2–5% of the psoriatic 
patients (4, 5). Genital skin can also be affected in cases 
of inverse psoriasis (synonym: flexural or intertriginous 
psoriasis) (2, 4, 5).
The external genital skin is generally classified as 
flexural skin, although it forms a unique area compri-
sing different structures and types of epithelium. The 
epithelium covering the different structures of the vulva 
changes from stratified, keratinised squamous cell epit-
helium on the outer parts to mucosa on the innermost 
regions (5, 6). Similarly, the male genital epithelium 
has a different pattern of keratinisation throughout the 
genital area. The prepuce forms the anatomical cover-
ing of the glans penis and is the junction between the 
mucosal surface of the glans and coronal sulcus and the 
keratinised squamous cell epithelium of the remaining 
external genital skin (7).
In general, the unique microenvironment of the genital 
region may have consequences for the clinical appear-
ance of skin diseases. Genital skin folds are susceptible 
to maceration and fissuring due to the combination of 
moisture, warmth and friction. In addition, the genital 
area is often exposed to mechanical and chemical irri-
tation. Consequently, the normal characteristics of com-
mon dermatoses may be lost or modified in the genital 
region. Moreover, as a result of their location, these 
dermatoses may be confused with sexually transmitted 
diseases. Because of the high sensitivity of the vulner-
able, thin genital skin and the increased penetration 
of topical treatments applied to this site of the body, 
treatment of genital lesions is a challenge. 
Psoriasis affecting genital skin may be associated 
with considerable morbidity, discomfort and embar-
rassment and may considerably impair quality of 
life and psychosexual wellbeing. This review covers 
both female and male genital psoriatic lesions. Epi-
demiology, aetiology, clinical and histopathological 
findings, diagnosis and the various treatment options 
are described.
MATERIALS AND METHODS
An extensive literature search was performed to collect evidence- 
based data on genital psoriasis. Relevant literature published 
between January 1988 and June 2009 was obtained from three 
computerised bibliographical databases: PubMed, EMBASE 
and the Cochrane Library. Additional papers were identified 
using the “related articles” button in PubMed. 
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Key words and selection criteria
As key words we used “psoriasis” or “psoriatic”, combined with 
“inverse”, “inversa”, “intertriginous”, “flexural” or “flexures”. 
Subsequently, these key words were combined with the follo-
wing search terms: “groin”, “groins”, “genital*” (truncated), 
“anogenital*” (truncated), “vulva*” (truncated), “penis”, 
“penile”, “foreskin”, “prepuce”, “preputial”, “penoscrotal”, 
“scrotal”, “scrotum”, “inguinal”, “anal”, “anus”, “diaper” and 
“napkin”. The search and selection of the literature was res-
tricted to publications written in English, Dutch, German or 
French. Because published data specific for genital psoriasis 
are extremely limited, we reviewed all available literature, 
including clinical trials, case reports, retrospective studies, and 
letters to the editor concerning all types of genital psoriasis.
Study selection: inclusion and exclusion criteria 
The selection of studies involved a two-stage process. Titles and 
abstracts of all identified citations were screened; full-text articles 
were obtained if potentially relevant according to the abstract. 
Articles without information on flexural or genital psoriasis 
were excluded during this first selection step. Articles present in 
more than one database were included once. Subsequently, two 
reviewers (KM and MvR) independently and critically assessed 
the articles for inclusion or exclusion, using a checklist. Levels 
of evidence and grading recommendations were determined 
according to the “Oxford Centre for Evidence-based Medicine 
Levels of Evidence” guidelines, version March 2009 (adapted 
from http://www.cebm.net/index.aspx?o=1025). The Oxford 
Centre for Evidence-based Medicine suggests levels of evidence 
(LoE) according to the study design. These levels vary between 
1a and 5 – the higher the number, the worse the quality of the 
evidence. Recommendations are graded from A (strong) to D 
(weak) based on the LoE. 
Articles covering all types of genital psoriatic lesions in all age 
groups were included. Articles on flexural psoriasis with inade-
quate/insufficient data on genital psoriasis (e.g. articles that did 
not discriminate between flexural and genital psoriasis or trials 
that did not assess the safety and efficacy of the investigated 
therapy on genital skin) were excluded. In addition, articles that 
referred only to other publications were excluded and the source 
data were retrieved instead. Articles in which genital psoriasis 
cases were excluded from the analysis, as well as articles about 
secondary outcome measures, case reports without any supple-
mentary information, and articles that were not available were 
also excluded. when there was disagreement about article selec-
tion, a third investigator (JdH) was consulted. Reference lists in 
the selected articles were scrutinised to identify other relevant 
articles that had been overlooked in the database search. Fig. 1 
illustrates the complete selection process. 
RESULTS
A total of 798 citations that were potentially relevant 
were identified. Of these, 184 articles seemed to be 
relevant according to their title and abstract and were 
selected for detailed evaluation. Forty-two articles were 
not available since they were published in journals that 
were unavailable via the libraries of nine European uni-
versities. For 98 articles the exclusion criteria appeared 
to be applicable on closer evaluation. These articles were 
excluded from further evaluation. In addition, a manual 
search of the reference lists retrieved a further 15 articles. 
Consequently, 59 full-text articles were considered ap-
pro priate for detailed evaluation (see references 8–66).
Epidemiology
Table I recapitulates the results of several question-
naire-based surveys, showing that involvement of the 
genital skin occurs in 29–40% of patients with psoriasis 
(8–12) [LoE: 4]. The genital area may frequently be in-
volved in cases of inverse psoriasis. Of 48 patients with 
inverse psoriasis, the external genitalia were involved 
in 38 (79.2%). All the cases concerned were diagnosed 
by two dermatologists (13) [LoE: 4].
Vulvar psoriasis [LoE: 4]. Psoriasis of the vulva was 
found in 25 of 1,000 women referred to special vulval 
clinics (14). In addition, in a group of 101 patients with 
chronic symptomatic (predominantly itching) vulvar 
disorders, two (2%) were caused by psoriasis (15).
Two articles focused on non-neoplastic vulvar biopsies. 
Two biopsies from 114 women who visited a multidis-
ciplinary clinic specialising in non-neoplastic diseases 
of the vagina and vulva were histologically diagnosed 
as vulvar psoriasis (16). Of 43 cases with clinical and 
pathological diagnoses of non-neoplastic alterations of 
the vulva, three were found to be suffering from psoriasis 
(17).
An investigation into the pattern of non-venereal der-
matoses of the female external genitalia, conducted in 
a dermatology and gynaecology outpatient department 
in South India, revealed that five patients out of a total 
of 120 (4.2%) had psoriasis (18). 
Vulvar psoriasis is also frequently seen in children. 
In an evaluation of 130 prepubertal girls with vulvar Fig. 1. The selection process for relevant articles on genital psoriasis.
 
Total citations identified from 
electronic databases 
PubMed (345) 
Embase (434) 
Cochrane (19) 
n=798 
Citations for first screening 
(potentially relevant) 
n=540 
Full text articles for detailed 
evaluation 
n=184 
Duplicate articles excluded 
n=258 
Citations obtained 
via manual search 
n=15 
Articles included in review 
n=59 
Excluded after examination of full 
text manuscript 
n=140 
- Unavailable (n=42) 
- Not relevant (n=98) 
• No relevant information on 
genital psoriasis (n=60) 
• No discrimination between 
flexural and genital psoriasis 
(n=22) 
• Focus: secondary endpoint 
(n=12) 
• Article only referring to other 
publications (n=4) 
Citations excluded after screening 
titles and abstracts 
n=356 
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complaints, psoriasis (17%) was the third most common 
cutaneous condition, after atopic or irritant dermatitis 
(33%) and lichen sclerosus (18%) (19). Additionally, 
others found psoriasis to be one of the most common 
non-venereal dermatoses in a group of prepubertal girls, 
affecting two (9.5%) of the 21 patients studied (18).
Penile psoriasis [LoE: 5]. One report stated that pso-
riasis of the penis can be diagnosed in 3% of male 
patients with alterations of the penile skin who visit 
specialised clinics (20). 
Aetiology
No articles describing or discussing the aetiology of 
genital psoriasis were retrieved in this systematic re-
view of the literature. 
Clinical presentation [LoE: 5]
Psoriatic lesions on the genital skin often present as 
well-demarcated, brightly erythematous, thin plaques 
and usually lack, due to maceration, the typical scaling 
that is apparent on other parts of the body (21–39). 
However, scales may be seen on the more keratinised 
regions of the genital skin (34, 40, 41). when scaling 
is present, it is often minimal and can easily be scraped 
off, leaving pinpoint bleedings (26, 27, 38, 42).
The appearance of vulvar psoriasis is often symmetri-
cal and can vary from silvery, scaling patches adjacent 
to the outer parts of the labia majora to moist greyish 
plaques or glossy red plaques without scaling in the skin 
folds (33, 35, 40, 42–45).
In male patients, both scrotal and penile skin may be 
affected. The glans penis is the area of male genital skin 
that is most commonly affected. Occasionally the entire 
penis, scrotum, and inguinal folds are involved (25, 26, 
30, 41, 46). whereas in uncircumcised males the well-
defined non-scaling plaques are most common under 
the prepuce and on the proximal glans, in circumcised 
male patients the red lesions are usually present on the 
glans and corona (25, 30, 41). Psoriatic genital lesions 
of the glans and corona in circumcised males can be 
more scaly than those usually seen in genital skin (25, 
41, 47). Some authors suggest that involvement of the 
genital mucosa may be diagnosed less frequently in 
women than in men (32, 34, 36).
Genital lesions may be accompanied by rhagades or fis-
sures, which can cause definite soreness (28, 48). Patients 
with genital psoriasis may also experience pruritus and/or 
a burning sensation in the affected area, which can range 
from minimal to marked (23, 26, 30, 36, 42, 49). Psoriasis 
is generally not associated with scarring. However, one 
case report described two patients with long-standing 
severe anogenital psoriasis that was associated with loss 
of the labia minora. Clinically, this mimicked the scarring 
associated with lichen sclerosus, but histopathologically 
the lesions were diagnosed as psoriasis (50). No other 
reports of genital scarring due to psoriasis were found in 
our systematic review of the literature. 
Due to the Koebner phenomenon, genital psoriasis may 
be worsened by irritation from urine and faeces, tight-
fitting clothes and sexual intercourse (26, 38, 40, 47). 
Pustular psoriasis. Although most genital psoriatic 
lesions represent plaque-type psoriasis, the genital area 
may also be affected by pustular psoriasis. Both gene-
ralised and localised pustular psoriatic eruptions may 
affect the genital skin (51–53). A case of a 23-year-old 
man with pustular psoriasis limited to the penis was 
described. The lesions presented as numerous white 
papules and pustules on an erythematous base (52). 
Another patient with recurrent episodes of multiple, 
painless, circinate, pustular eruptions over the glans 
penis was found to be suffering from pustular psoriasis 
on histopathological examination (53). No reports of 
female genital pustular psoriasis were found in our 
systematic review of the literature. 
Children. Although there is no difference in the presen-
tation of genital psoriasis between children and adults, 
psoriatic napkin eruption deserves special attention in 
this review. It has been debated whether this condition 
should be regarded as psoriasis, seborrhoeic dermatitis 
or a Candida infection, although it is currently assumed 
that both localised and disseminated psoriatic napkin 
eruptions may represent psoriasis or a precursor to 
psoriasis in some children (37, 54–58) [LoE: 4]. The 
eruption is characterised by confluent erythematous, 
and sometimes silvery-squamous, plaques with well-
defined borders in the napkin area, with the genitals 
possibly also being affected. Most often the lesions are 
surrounded by psoriasis-like papules, and may spread 
to the trunk, limbs and, very frequently, the scalp and 
Table I. Involvement of the genital skin in patients with psoriasis
Source
Author, year (ref.)
Number of patients Genital involvement
Total Male Female n % Male: Female (%)
Hellgren, 1964 (8) 119 73 46 34 28.6 24:10 (32.9:21.7)
Farber et al., 1968 (9) 2144 968 1176 663 30.9 416:247 (43.0:21.0)
Farber & Nall, 1974 (10) 5600 2562 3038 2245 40.1 1251:994 (48.8:32.7)
van de Kerkhof et al., 2000 (11) 839 386 453 243 29.0 N/A 
Fouéré et al., 2005 (12) 1281  N/A  N/A 410 32.0 N/A
N/A: not applicable.
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face (37, 55, 56, 58–61) [LoE: 4 and 5]. In a clinical 
review of 1,262 cases of childhood psoriasis, 13% of 
the children studied had a psoriatic napkin eruption 
with dissemination and approximately 4% had a lo-
calised psoriatic napkin eruption. In children younger 
than two years of age psoriatic napkin eruption with 
dissemination was the most common type of psoriasis. 
Moreover, anogenital psoriasis occurred four times 
more often in children over two years of age than in 
children under two years of age (37) [LoE: 4].
Diagnosis [LoE: 4 and 5]
The diagnosis of genital psoriasis can usually be made 
on the basis of its clinical appearance. Genital psoriatic 
lesions may be the only psoriatic features in a parti-
cular patient, but more often they are part of a more 
generalised form of psoriasis. Confirmatory lesions 
elsewhere or other clinical signs of psoriasis (such as 
nail deformities or joint complaints) may be present 
(19, 22–25, 27, 28, 30, 31, 33, 35, 36, 41–43, 45, 46). 
Skin biopsies are therefore rarely needed, but should 
not be omitted in inconclusive cases. Table II shows 
the possible differential diagnoses in cases of genital 
psoriasis, as mentioned in source articles. 
Histologically there is no apparent difference between 
genital and non-genital psoriasis (14, 16, 17, 22, 23, 
27, 28, 34, 41). However, the typical characteristics 
of psoriasis may be less evident in vulvar and penile 
psoriatic lesions, which may necessitate a careful search 
for subtle signs in these cases (17, 50). 
Therapy 
Case reports [LoE: 4 and 5]. The current literature 
provides extremely limited evidence for the efficacy 
and safety of treatment options for genital psoriasis. 
Only six casuistic reports and one open-label study 
have roughly described the effects of therapies used. 
An overview of these reports can be found in Table III. 
Based on these reports, 1%  pimecrolimus cream and 
topical cyclosporine may produce beneficial effects 
when used to treat plaque psoriasis of the glans penis 
and prepuce (62, 63). The application of an ointment 
containing betamethasone-17-valerate (a potent cor-
ticosteroid) three times a day was useful for psoriasis 
of the labium majus in one patient (42). Corticosteroid 
ointment was effective in only three out of 67 children 
with napkin plaque psoriasis, while coal-tar preparations 
were helpful in the remaining 64 patients. Therapy with 
zinc paste and salicylic acid was ineffective in these 
patients (54). Ketoconazole cream was effective against 
lesions in the napkin area of a four-month-old boy suffe-
ring from napkin psoriasis with pustular dissemination, 
where examination of the scales was positive for fungal 
infection (64).
Two case reports of pustular psoriasis of the glans 
and penile shaft were included in our study. One of 
these suggests a minor effect of the combination of a 
weak corticosteroid with coal-tar. Systemic treatment 
with itraconazole (200 mg twice daily for 6 weeks) 
demonstrated some effect, whereas dapsone (100 mg 
daily for 4 weeks) was very effective (52, 53).
Expert opinions [LoE: 5].Twenty-four articles reflected 
merely the opinions of experts on the preferred treat-
ments for genital psoriasis. we have summarised these 
different opinions in Table SI (http://adv.medicaljour-
nals.se/article/abstract/10.2340.00015555-0988). 
Corticosteroids. All authors advise the use of topical 
corticosteroids. Most of the authors are reluctant in the 
prescription of corticosteroids for genital psoriasis and 
only recommend the use of weak (and sometimes, if 
necessary, moderate) steroids, which may be combi-
ned with vitamin D analogues or mild tar preparations 
(25, 26, 32–34, 40, 41, 47, 60, 61). Although weak 
cortico steroids are preferable because of their mild side-
effects, they often seem insufficiently potent to induce 
a response. Some experts therefore advise short-term, 
intermittent use of moderate-to-potent corticosteroids 
to induce a response, followed by a subsequent gradual 
shift towards a weaker steroid preparation (14, 35, 
36, 43–45, 65). On the contrary, other authors advise 
intensive, short-term, intermittent use of potent corti-
costeroids (22, 23, 29, 30, 46, 59, 66).
Coal-tar preparations. The use of mild topical tar 
preparations (i.e. 1–5% liquor carbonis detergens in 
aqueous cream) for the treat ment of genital psoriasis is 
frequently recommended and is the second most advised 
topical therapy after corticosteroids. Tar may be used 
as an individual topical therapy or, when (maintenance) 
treatment with weak potent corticosteroids is insuf-
ficient, be combined or alternated with topical steroids 
(25, 35, 36, 40, 41, 44, 45, 65). Tar may also be used 
Table II. Possible differential diagnoses in cases of genital psoriasis, 
as mentioned in source articles
Differential diagnosis References 
Dermatitis (variants: seborrhoeic dermatitis, 
contact dermatitis, atopic dermatitis, 
spongiotic dermatitis)
16, 22, 23, 34, 35, 42, 45, 
52, 55, 59
Dermatophytosis or candidiasis 16, 22, 34, 40, 42, 47, 59
Squamous cell carcinoma (in situ) (variants: 
morbus Bowen, Bowenoid papulosis, 
erythroplasia de Queyrat)
21, 26, 30, 34, 41, 46, 52
Plasma-cell balanitis or vulvitis 21, 34, 40, 41, 46, 52
Lichen planus 22, 41, 42, 46, 52
Secondary or tertiary (pustular) syphilis 22, 42, 46, 52, 53
Reiter’s syndrome (balanitis circinata) 41, 47, 52, 53
Lichen simplex chronicus (excoriated) 16, 23, 42
Extramammary Paget disease 21, 42
Intertrigo 22, 34
Fixed drug eruption 41, 52
Lichen nitidus 52
Lichen sclerosus 23
Scabies or pediculosis pubis 42
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for napkin psoriasis, for example mixed with zinc oxide 
(60, 61). Despite these positive opinions regarding the 
use of coal-tar preparations, there are also reports that 
advise against the use of tar preparations because of 
their potential to cause irritation (22, 29, 32, 33). Others 
point out the importance of the choice of the vehicle, 
as tar gels may be too irritating to sensitive genital skin 
and tar ointment may cause folliculitis in hairy areas. 
They suggest that mixing a tar preparation with a steroid 
preparation may reduce irritation (40).
Vitamin D analogues.Vitamin D analogues are another 
possible non-steroidal treatment for genital psoriatic 
lesions, in particular those affecting male genital skin 
(25, 26, 30, 46). They can be prescribed as mo notherapy 
or in combination with steroid preparations (25). 
Vitamin D analogues may cause irritation, which may 
be minimised by their combination with steroids (25, 
46). Nevertheless, some authors advise against the use 
of vitamin D analogues, as these may be too irritating 
to apply to the genital area (33, 60). 
Immunomodulators. One author expressed the opinion 
that the use of pimecrolimus ointment or tacrolimus 
cream may be useful (33), while acknowledging that they 
may cause local irritation and stinging. Monitoring of 
possible complications of immunomodulators is advised, 
as they can cause irritant or allergic contact dermatitis, 
candidiasis, or (re)activation of viral skin infections. 
Other modalities/General advice. Suspected concurrent 
bacterial or fungal infections of the genital area should 
be treated with topical antibiotics or ketoconazole/mico-
nazole, respectively, to eliminate the possible Koebner 
effect (23, 26, 30, 32, 35, 36, 40, 46, 60). Moreover, 
minimising contact with local irritating factors and the 
use of mild emollients may be useful in the treatment 
of genital psoriasis (29, 40, 46, 59). 
Systemic therapy is no common practice for isolated 
genital psoriasis. Nevertheless, such treatment modalities 
may also be beneficial for genital lesions if prescribed 
because of severe and extensive psoriasis (32, 33). 
Anthralin, tazarotene, ultraviolet (UV)-light and 
laser therapy should be avoided in the genital area (22, 
33, 40).
Therapy-resistant penile and vulvar plaques should 
always be clinically and histologically re-evaluated to 
rule out malignancy (26, 30, 42).
CONCLUSION
An extensive, systematic literature search revealed data 
concerning the epidemiology, clinical presentation and 
therapy of psoriasis of the genital skin. Remarkably 
few studies have been published on this topic. Our 
literature review demonstrates that this hidden skin 
disease will affect a significant proportion of patients 
with psoriasis at some time during their disease and is 
a frequent cause of genital complaints. Ta
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It remains to be established whether genital discomfort 
in psoriatic patients is caused by genital psoriasis or by a 
comorbidity of the genital skin/mucosa. Examination of 
the whole skin, including the genital region, is important 
and should be implemented in daily clinical practice. 
Unfortunately, there is often no discrimination be-
tween flexural and genital psoriasis in existing publica-
tions. Moreover, the current literature often lacks data 
on the efficacy and safety of investigated treatments 
for genital skin, and therefore the treatment of genital 
psoriasis is often empirical. Based on the available 
literature, the following treatment paradigm is advised 
for genital psoriasis: 
First-line treatment: topical corticosteroid. Second-
line treatment: vitamin D preparation or tar-based 
treatment.
The general advice is to start with weak cortico-
s teroids and, in cases of resistance to treatment, to 
increase the strength of the corticosteroid preparation. 
Treatment with potent corticosteroids should be limi-
ted to a few weeks in view of their atrophic effects, 
in particular on genital skin. The addition of topical 
vitamin D or coal-tar preparations has been suggested 
to be effective. They can reduce the side-effects of 
cortico steroids, although irritation may restrict their 
application. Evidence for the use of immunomodulators 
on genital skin is scarce. They should be regarded as 
third-line treatment options.
These recommendations are based on case series 
and expert opinions only (grade of recommendation: 
D). Further studies are urgently needed to determine 
the efficacy and safety of potential treatments and to 
improve care for patients with genital psoriasis.
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